OB-GYNs Revise 1930s Prenatal Care Schedule
What: ACOG wants to modernize prenatal care by reducing visit counts for low-risk pregnancies while increasing visit length and focus on social determinants. Many patients don’t start care early or receive all services on time.
Key Line: “The standard recommendation of 12 to 14 visits doesn’t ensure that patients receive necessary care when nearly a quarter don’t go to their first appointment until after the first trimester…”
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
Guardian report details how U.S. medical trainees are seeking abortion education abroad.
NWLC report warns that birth control access is increasingly under threat post-Roe.
The influential Women’s Health Initiative will shut down without federal support.
New York Times honors the woman who funded and enabled the development of the birth control pill.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
Meghan Markle discusses rare and life-threatening postpartum condition on new podcast.
Estrogen’s role in the brain goes far beyond reproduction, NYT reports.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
JAMA study shows a 28% increase in maternal deaths from 2018 to 2022.
A blood test may soon predict postpartum depression before symptoms arise.
Once academic, now viral—this disinfectant may be the most powerful skin-safe cleanser yet.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
A major study ties maternal diabetes to neurodevelopmental issues in children.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Study identifies fast, simple method for predicting life-threatening postpartum bleeding.
A study finds women with incontinence are more likely to have heart disease risk factors.
Federal panel reinforces need for breastfeeding help during and after pregnancy.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
Women’s health startups raised $2.6B in VC funding last year, but exits remain elusive.